Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Corvus Pharmaceuticals Inc buy LADENBURG THALM/SH SH

Start price
€5.26
16.09.24 / 50%
Target price
€18.87
16.09.25
Performance (%)
-11.31%
End price
€4.67
17.09.25
Summary
This prediction ended on 17.09.25 with a price of €4.67. The prediction for Corvus Pharmaceuticals Inc disappointed with a performance of -11.31%. LADENBURG_THALM_SH_S has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Corvus Pharmaceuticals Inc -5.200% -5.200% -6.447%
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

Comments by LADENBURG_THALM_SH_S for this prediction

In the thread Corvus Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) -11.31%
Target price 18.873
Change
Ends at 16.09.25

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its price target raised by analysts at LADENBURG THALM/SH SH from $12.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for CRVS provided by MarketBeat

In the thread Trading Corvus Pharmaceuticals Inc
Prediction Buy
Perf. (%) -11.31%
Target price 18.873
Change
Ends at 16.09.25

Die von LADENBURG_THALM_SH_S gewählte maximale Laufzeit wurde überschritten